262 related articles for article (PubMed ID: 21936348)
1. [Clinical efficacy and costs of the three-year specific allergen immunotherapy--retrospective study].
Targowski T; Jahnz-Rózyk K; Przekora P; Kucharczyk A; Owczarek W
Pol Merkur Lekarski; 2011 Aug; 31(182):106-10. PubMed ID: 21936348
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy.
Pokladnikova J; Krcmova I; Vlcek J
Ann Allergy Asthma Immunol; 2008 May; 100(5):482-9. PubMed ID: 18517082
[TBL] [Abstract][Full Text] [Related]
3. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
4. Pharmacoeconomics of subcutaneous allergen immunotherapy.
Incorvaia C; Agostinis F; Amoroso S; Ariano R; Barbato A; Bassi M; Cadario G; Campi P; Cardinale F; Romano C; Ciprandi G; D'Anneo R; Dal Bo S; Di Gioacchino M; Fiocchi A; Galimberti M; Galli E; Giovannini M; La Grutta S; Lombardi C; Marcucci F; Marseglia GL; Mastrandrea F; Minelli M; Nettis E; Novembre E; Ortolani C; Pajno G; Piras PP; Passalacqua G; Patriarca G; Pucci S; Quercia O; Romano A; Schiavino D; Sforza M; Tosca MA; Tripodi S; Zambito M; Puccinelli P; Frati F
Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():17-20. PubMed ID: 18924462
[TBL] [Abstract][Full Text] [Related]
5. Allergen immunotherapy.
Frew AJ
J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S306-13. PubMed ID: 20176266
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France.
Omnes LF; Bousquet J; Scheinmann P; Neukirch F; Jasso-Mosqueda G; Chicoye A; Champion L; Fadel R
Eur Ann Allergy Clin Immunol; 2007 May; 39(5):148-56. PubMed ID: 17626329
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma.
Brüggenjürgen B; Reinhold T; Brehler R; Laake E; Wiese G; Machate U; Willich SN
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):316-24. PubMed ID: 18814456
[TBL] [Abstract][Full Text] [Related]
8. The health economics of allergen immunotherapy.
Hankin CS; Cox L; Bronstone A
Immunol Allergy Clin North Am; 2011 May; 31(2):325-41, x. PubMed ID: 21530823
[TBL] [Abstract][Full Text] [Related]
9. A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma.
Rak S; Heinrich C; Jacobsen L; Scheynius A; Venge P
J Allergy Clin Immunol; 2001 Dec; 108(6):921-8. PubMed ID: 11742269
[TBL] [Abstract][Full Text] [Related]
10. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual.
Cox L; Wallace D
Immunol Allergy Clin North Am; 2011 Aug; 31(3):561-99. PubMed ID: 21737043
[TBL] [Abstract][Full Text] [Related]
11. GA² LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma.
Zuberbier T; Bachert C; Bousquet PJ; Passalacqua G; Walter Canonica G; Merk H; Worm M; Wahn U; Bousquet J
Allergy; 2010 Dec; 65(12):1525-30. PubMed ID: 21039596
[TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R
Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
Ibáñez Sendín MD
Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
[TBL] [Abstract][Full Text] [Related]
14. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
Silny W; Czarnecka-Operacz M
Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
[TBL] [Abstract][Full Text] [Related]
15. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
Halken S
Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
[TBL] [Abstract][Full Text] [Related]
16. [Cluster-immunotherapy in seasonal allergic rhinitis: safety aspects of induction therapy with depot allergoids (Purethal)].
Hansen I; Hörmann K; Stuck BA; Schneider-Gêne S; Mösges R; Klimek L
Laryngorhinootologie; 2003 Aug; 82(8):558-63. PubMed ID: 12915987
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma.
Nasser S; Vestenbaek U; Beriot-Mathiot A; Poulsen PB
Allergy; 2008 Dec; 63(12):1624-9. PubMed ID: 19032235
[TBL] [Abstract][Full Text] [Related]
18. Role of immunmodulators in allergen-specific immunotherapy.
Kopp MV
Allergy; 2011 Jun; 66(6):792-7. PubMed ID: 21332502
[TBL] [Abstract][Full Text] [Related]
19. Utilization and cost of immunotherapy for allergic asthma and rhinitis.
Donahue JG; Greineder DK; Connor-Lacke L; Canning CF; Platt R
Ann Allergy Asthma Immunol; 1999 Apr; 82(4):339-47. PubMed ID: 10227332
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
Polzehl D; Keck T; Riechelmann H
Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
